- Home
- LNTH vs TX Comparison
LNTH vs TX Comparison
Compare LNTH & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TX
- Stock Information
- Founded
- LNTH 1956
- TX 1961
- Country
- LNTH United States
- TX Luxembourg
- Employees
- LNTH N/A
- TX N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TX Steel/Iron Ore
- Sector
- LNTH Health Care
- TX Industrials
- Exchange
- LNTH Nasdaq
- TX Nasdaq
- Market Cap
- LNTH 6.3B
- TX 6.7B
- IPO Year
- LNTH 2015
- TX 2006
- Fundamental
- Price
- LNTH $94.05
- TX $28.76
- Analyst Decision
- LNTH Strong Buy
- TX Strong Buy
- Analyst Count
- LNTH 6
- TX 2
- Target Price
- LNTH $132.67
- TX $55.00
- AVG Volume (30 Days)
- LNTH 723.3K
- TX 168.7K
- Earning Date
- LNTH 02-20-2025
- TX 02-18-2025
- Dividend Yield
- LNTH N/A
- TX 10.78%
- EPS Growth
- LNTH 304.57
- TX N/A
- EPS
- LNTH 6.02
- TX 0.40
- Revenue
- LNTH $1,496,799,000.00
- TX $18,703,544,000.00
- Revenue This Year
- LNTH $19.64
- TX $6.04
- Revenue Next Year
- LNTH $5.16
- TX $2.76
- P/E Ratio
- LNTH $15.62
- TX $71.57
- Revenue Growth
- LNTH 24.15
- TX 15.27
- 52 Week Low
- LNTH $50.20
- TX $28.40
- 52 Week High
- LNTH $126.89
- TX $44.44
- Technical
- Relative Strength Index (RSI)
- LNTH 53.53
- TX 38.93
- Support Level
- LNTH $89.92
- TX $28.84
- Resistance Level
- LNTH $97.25
- TX $29.39
- Average True Range (ATR)
- LNTH 3.42
- TX 0.59
- MACD
- LNTH 0.05
- TX 0.14
- Stochastic Oscillator
- LNTH 67.86
- TX 18.95
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.